Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hourmant

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|April 1, 1994
Is the incidence of kidney rejection episodes higher in combined kidney/pancreas than in single kidney transplant patients?D Cantarovich, M Hourmant, J Dantal, et al.
Transplantation Proceedings|April 1, 1994
OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantationD Cantarovich, M Hourmant, J Dantal, et al.
Nephrologie|January 1, 1981
[Kinetics of plasma and urine aluminium after renal grafting (author's transl)]M Hourmant, J P Soulillou, H L Boiteau, et al.
Lancet (London, England)|March 21, 1998
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensJ Dantal, M Hourmant, D Cantarovich, et al.
Transplantation Proceedings|June 1, 1992
Lipid metabolism following heterotopic pancreas transplantation with special reference to steroid therapyD Cantarovich, B Lucas, M Krempf, et al.
Transplantation Proceedings|June 1, 1992
Long-term glucose homeostasis and insulin secretion following segmental heterotopic pancreas transplantationD Cantarovich, A Murat, J Paineau, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1991
Effect of the number of pregraft blood transfusions in kidney graft recipients treated with bioreagents and cyclosporin AR Baatard, J Dantal, M Hourmant, et al.
Transplantation|May 8, 2000
Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive casesD Cantarovich, M Giral-Classe, M Hourmant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
Late ureteral stenosis following renal transplantation: risk factors and impact on patient and graft survivalG Karam, J-F Hétet, F Maillet, et al.
Transplantation Proceedings|February 1, 1989
Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulinD Cantarovich, B Le Mauff, M Hourmant, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|April 1, 1994
Is the incidence of kidney rejection episodes higher in combined kidney/pancreas than in single kidney transplant patients?D Cantarovich, M Hourmant, J Dantal, et al.
Transplantation Proceedings|April 1, 1994
OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantationD Cantarovich, M Hourmant, J Dantal, et al.
Nephrologie|January 1, 1981
[Kinetics of plasma and urine aluminium after renal grafting (author's transl)]M Hourmant, J P Soulillou, H L Boiteau, et al.
Lancet (London, England)|March 21, 1998
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensJ Dantal, M Hourmant, D Cantarovich, et al.
Transplantation Proceedings|June 1, 1992
Lipid metabolism following heterotopic pancreas transplantation with special reference to steroid therapyD Cantarovich, B Lucas, M Krempf, et al.
Transplantation Proceedings|June 1, 1992
Long-term glucose homeostasis and insulin secretion following segmental heterotopic pancreas transplantationD Cantarovich, A Murat, J Paineau, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1991
Effect of the number of pregraft blood transfusions in kidney graft recipients treated with bioreagents and cyclosporin AR Baatard, J Dantal, M Hourmant, et al.
Transplantation|May 8, 2000
Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive casesD Cantarovich, M Giral-Classe, M Hourmant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
Late ureteral stenosis following renal transplantation: risk factors and impact on patient and graft survivalG Karam, J-F Hétet, F Maillet, et al.
Transplantation Proceedings|February 1, 1989
Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulinD Cantarovich, B Le Mauff, M Hourmant, et al.
Pageof 10